The Food and Drug Administration is warning consumers to stop using a specific brand of COVID-19 tests, claiming there is a high chance they will produce false results.
In a statement, the agency is urging people to stop using the LuSys Laboratories COVID-19 Antigen Test and the LuSys Laboratories COVID-19 IgG/IgM Antibody Test.
The FDA said the tests may be sold under company names Luscient Diagnostics or Vivera Pharmaceuticals, or the trade name EagleDx.
“The performance of these tests has not been adequately established and the FDA believes there is likely a high risk of false results when using these tests,” the FDA said in its statement.
People who used the tests are advised to contact their health care providers. Health professionals are advised to consider retesting if they suspect an inaccurate result.
Last November, the agency warned about the increase in bogus COVID tests, vaccines and treatments during the pandemic. The FDA’s January alert arrives as Americans scramble to find COVID-19 at-home test kits.
Test prices have also increased at stores including Walmart and Kroger in recent weeks.